Labrique AB, Zaman K, Hossain Z, Saha P, Yunus M, Hossain A, Ticehurst J, Nelson KE. Population seroprevalence of hepatitis E virus antibodies in rural Banglasesh. Am J Trop Med Hyg 2009; 81: 875-881.
Johnston CP, Qiu H, Ticehurst JR, Dickson C, Rosenbaum P, Lawson P, Stokes AB, Lowenstein CJ, Kaminsky M, Cosgrove SE, Green KY, Perl TM. Outbreak management and implications of a nosocomial norovirus outbreak. Clin Infect Dis 2007; 45: 534-540.
Ticehurst JR, Hamzeh FM, Thomas DL. Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis. J Clin Microbiol 2007; 45: 2426-2433.
Ticehurst JR, Aird DZ, Dam LM, Borek AP, Hargrove JT, Carroll KC. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 2006; 44: 1145-1149.
Netski DN, Wang X-H, Thomas DL, Mehta SH, Nelson K, Celentano D, Thongsawat S, Maneekarn N, Suriyan V, Jittiwutikorn J, Ticehurst JR. Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in Thai injection drug users. J Clin Microbiol 2004; 42: 1631-1636.
Madej RM, Caliendo AM, Day SP, Ferreira-Gonzalez A, Krajden M, Loeffelholz M, Nolte FS, Piatak M, Pope L, Ticehurst J. Quntitative molecular methods for infectious diseases: Approved Guideline MM6-A. Clinical Laboratory Standards Institute. 2003.
Barker PE, Watson MS, Ticehurst JR, Colbert JC, O'Connell CD. NIST physical standards for DNA-based medical testing. J Clin Lab Analysis 2002; 16: 5-10.




